Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 23.17
(-1.49%)
CNY 23.17
(-1.49%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.27 Billion CNY | 4.64% |
| 2022 | 2.01 Billion CNY | 74.84% |
| 2021 | 1.15 Billion CNY | 37.56% |
| 2020 | 838.94 Million CNY | 33.12% |
| 2019 | 630.23 Million CNY | 25.16% |
| 2018 | 503.53 Million CNY | 29.49% |
| 2017 | 388.85 Million CNY | 35.96% |
| 2016 | 286 Million CNY | 27.13% |
| 2015 | 224.97 Million CNY | 43.42% |
| 2014 | 156.86 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 602.94 Million CNY | 33.29% |
| 2024 Q1 | 554.15 Million CNY | -1.56% |
| 2024 Q2 | 538.1 Million CNY | -2.89% |
| 2023 FY | 2.11 Billion CNY | 4.64% |
| 2023 Q3 | 571.88 Million CNY | -2.96% |
| 2023 Q2 | 589.32 Million CNY | 8.1% |
| 2023 Q1 | 545.18 Million CNY | -11.82% |
| 2023 Q4 | 562.92 Million CNY | -1.57% |
| 2022 Q1 | 381.86 Million CNY | 12.57% |
| 2022 Q3 | 556.21 Million CNY | 20.53% |
| 2022 Q4 | 618.27 Million CNY | 11.16% |
| 2022 FY | 2.01 Billion CNY | 74.84% |
| 2022 Q2 | 461.45 Million CNY | 20.84% |
| 2021 Q3 | 324.35 Million CNY | 29.46% |
| 2021 Q4 | 339.23 Million CNY | 4.59% |
| 2021 Q1 | 239.92 Million CNY | -9.62% |
| 2021 FY | 1.15 Billion CNY | 37.56% |
| 2021 Q2 | 250.54 Million CNY | 4.43% |
| 2020 Q3 | 201.25 Million CNY | 7.15% |
| 2020 Q2 | 187.83 Million CNY | 1.87% |
| 2020 Q1 | 184.39 Million CNY | 8.23% |
| 2020 FY | 838.94 Million CNY | 33.12% |
| 2020 Q4 | 265.46 Million CNY | 31.9% |
| 2019 Q4 | 170.36 Million CNY | 4.95% |
| 2019 Q3 | 162.33 Million CNY | 7.59% |
| 2019 Q2 | 150.88 Million CNY | 2.89% |
| 2019 Q1 | 146.64 Million CNY | -3.81% |
| 2019 FY | 630.23 Million CNY | 25.16% |
| 2018 Q4 | 152.46 Million CNY | 19.23% |
| 2018 FY | 503.53 Million CNY | 29.49% |
| 2018 Q3 | 127.86 Million CNY | 27.03% |
| 2018 Q2 | 100.65 Million CNY | -5.97% |
| 2018 Q1 | 107.04 Million CNY | 18.73% |
| 2017 Q4 | 90.15 Million CNY | 0.0% |
| 2017 FY | 388.85 Million CNY | 35.96% |
| 2016 FY | 286 Million CNY | 27.13% |
| 2015 FY | 224.97 Million CNY | 43.42% |
| 2014 FY | 156.86 Million CNY | 0.0% |